PROFESSIONAL EDITION

The largest community of pharma leaders

Editor´s Pick

      Moderna Files for Authorization with Health Canada for its COVID-19 Vaccine in Adolescents

      CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted for authorization...

      Moderna Announces Agreement to Supply the Republic of Botswana with its COVID-19 Vaccine

      CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a supply agreement with the Government...

      Bayer Acquires Noria and PSMA Therapeutics to Expand Pipeline in Prostate Cancer

      WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced that it has entered into an agreement to acquire Noria Therapeutics Inc. (Noria) and PSMA Therapeutics Inc. Through this...

      Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands

      CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has entered into an...

      UNICEF and Moderna Announce Long Term Agreement to Supply Vaccine on Behalf of the COVAX Facility

      CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and UNICEF today announced that they have signed...

      Recent Articles

      Post